Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Apr;87(4):1274–1279. doi: 10.1172/JCI115129

Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.

J Haarbo 1, P Leth-Espensen 1, S Stender 1, C Christiansen 1
PMCID: PMC295153  PMID: 1901319

Abstract

Cardiovascular disease is currently the leading cause of death among women in the United States. To investigate the effect of postmenopausal hormone therapy on atherogenesis, we studied 75 cholesterol-fed female rabbits for 19 wk. The rabbits were randomly assigned to five groups. Four groups underwent bilateral ovariectomy followed by treatment with either 17 beta-estradiol, 17 beta-estradiol plus norethisterone acetate, 17 beta-estradiol plus levonorgestrel, or placebo. The fifth group had a sham operation and received placebo. The hormone groups had only one-third of the aortic accumulation of cholesterol found in the placebo groups, a difference that was highly statistically significant (P less than 0.0001). No significant differences in aortic accumulation of cholesterol were found in the hormone groups. This indicates that estrogen attenuates atherogenesis in cholesterol-fed ovariectomized rabbits and that two commonly prescribed progestogens do not counteract the effect. The beneficial effect of estradiol could only partly be explained by its lowering effects on serum total cholesterol or VLDL cholesterol, which implies that estradiol possesses additional beneficial effects, possibly a direct action on the arterial wall.

Full text

PDF
1274

Images in this article

1278Image
on p.1278

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bush T. L., Barrett-Connor E., Cowan L. D., Criqui M. H., Wallace R. B., Suchindran C. M., Tyroler H. A., Rifkind B. M. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987 Jun;75(6):1102–1109. doi: 10.1161/01.cir.75.6.1102. [DOI] [PubMed] [Google Scholar]
  3. Bush T. L., Barrett-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev. 1985;7:89–104. [PubMed] [Google Scholar]
  4. Bush T. L., Fried L. P., Barrett-Connor E. Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem. 1988;34(8B):B60–B70. [PubMed] [Google Scholar]
  5. Byrjalsen I., Riis B. J., Christiansen C. The measurement of secretory endometrial protein PP14 in serum from postmenopausal women receiving unopposed estrogen or continuously combined estrogen/progestogen. Gynecol Endocrinol. 1989 Jun;3(2):143–152. doi: 10.3109/09513598909152461. [DOI] [PubMed] [Google Scholar]
  6. Clarkson T. B., Adams M. R., Kaplan J. R., Shively C. A., Koritnik D. R. From menarche to menopause: coronary artery atherosclerosis and protection in cynomolgus monkeys. Am J Obstet Gynecol. 1989 May;160(5 Pt 2):1280–1285. doi: 10.1016/s0002-9378(89)80013-4. [DOI] [PubMed] [Google Scholar]
  7. Colditz G. A., Willett W. C., Stampfer M. J., Rosner B., Speizer F. E., Hennekens C. H. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987 Apr 30;316(18):1105–1110. doi: 10.1056/NEJM198704303161801. [DOI] [PubMed] [Google Scholar]
  8. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  9. Fischer G. M., Swain M. L. Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis. 1985 Feb;54(2):177–185. doi: 10.1016/0021-9150(85)90177-7. [DOI] [PubMed] [Google Scholar]
  10. Fotherby K. Pharmacokinetics of progestational compounds. Maturitas. 1986 Jul;8(2):123–132. doi: 10.1016/0378-5122(86)90019-8. [DOI] [PubMed] [Google Scholar]
  11. Fåhraeus L., Larsson-Cohn U., Wallentin L. L-norgestrel and progesterone have different influences on plasma lipoproteins. Eur J Clin Invest. 1983 Dec;13(6):447–453. doi: 10.1111/j.1365-2362.1983.tb00127.x. [DOI] [PubMed] [Google Scholar]
  12. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  13. Henriksson P., Stamberger M., Eriksson M., Rudling M., Diczfalusy U., Berglund L., Angelin B. Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur J Clin Invest. 1989 Aug;19(4):395–403. doi: 10.1111/j.1365-2362.1989.tb00248.x. [DOI] [PubMed] [Google Scholar]
  14. Hirvonen E., Mälkönen M., Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med. 1981 Mar 5;304(10):560–563. doi: 10.1056/NEJM198103053041002. [DOI] [PubMed] [Google Scholar]
  15. Hough J. L., Zilversmit D. B. Effect of 17 beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis. 1986 Jan-Feb;6(1):57–63. doi: 10.1161/01.atv.6.1.57. [DOI] [PubMed] [Google Scholar]
  16. Jensen J., Nilas L., Christiansen C. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy. Br J Obstet Gynaecol. 1986 Jun;93(6):613–618. doi: 10.1111/j.1471-0528.1986.tb08035.x. [DOI] [PubMed] [Google Scholar]
  17. Jensen J., Riis B. J., Strøm V., Christiansen C. Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women. Br J Obstet Gynaecol. 1987 Feb;94(2):130–135. doi: 10.1111/j.1471-0528.1987.tb02339.x. [DOI] [PubMed] [Google Scholar]
  18. King R. J., Whitehead M. I., Campbell S., Minardi J. Biochemical studies on endometrium from postmenopausal women receiving hormone replacement therapy. Postgrad Med J. 1978;54 (Suppl 2):65–68. [PubMed] [Google Scholar]
  19. Kushwaha R. S., Hazzard W. R. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism. 1981 Apr;30(4):359–366. doi: 10.1016/0026-0495(81)90116-5. [DOI] [PubMed] [Google Scholar]
  20. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  21. Ma P. T., Yamamoto T., Goldstein J. L., Brown M. S. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol. Proc Natl Acad Sci U S A. 1986 Feb;83(3):792–796. doi: 10.1073/pnas.83.3.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Persson I., Adami H. O., Bergkvist L., Lindgren A., Pettersson B., Hoover R., Schairer C. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ. 1989 Jan 21;298(6667):147–151. doi: 10.1136/bmj.298.6667.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ross R. K., Paganini-Hill A., Mack T. M., Henderson B. E. Cardiovascular benefits of estrogen replacement therapy. Am J Obstet Gynecol. 1989 May;160(5 Pt 2):1301–1306. doi: 10.1016/s0002-9378(89)80017-1. [DOI] [PubMed] [Google Scholar]
  24. Souadjian J. V., Kottke B. A., Titus J. L. Estrogen effect on spontaneous atherosclerosis. Experimental studies in white carneau pigeon. Arch Pathol. 1968 May;85(5):463–467. [PubMed] [Google Scholar]
  25. Stampfer M. J., Willett W. C., Colditz G. A., Rosner B., Speizer F. E., Hennekens C. H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985 Oct 24;313(17):1044–1049. doi: 10.1056/NEJM198510243131703. [DOI] [PubMed] [Google Scholar]
  26. Wallace R. B., Hoover J., Barrett-Connor E., Rifkind B. M., Hunninghake D. B., Mackenthun A., Heiss G. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Report from the Medications Working Group of the Lipid Research Clinics Program. Lancet. 1979 Jul 21;2(8134):112–115. [PubMed] [Google Scholar]
  27. Whitehead M. I., Townsend P. T., Pryse-Davies J., Ryder T. A., King R. J. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med. 1981 Dec 31;305(27):1599–1605. doi: 10.1056/NEJM198112313052701. [DOI] [PubMed] [Google Scholar]
  28. Witteman J. C., Grobbee D. E., Kok F. J., Hofman A., Valkenburg H. A. Increased risk of atherosclerosis in women after the menopause. BMJ. 1989 Mar 11;298(6674):642–644. doi: 10.1136/bmj.298.6674.642. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES